Ex parte ROMANO et al. - Page 13




          Appeal No. 1998-0296                                                        
          Application 08/431,312                                                      


          recite this argued limitation.                                              
               We note that Appellants have not argued that Ina has                   
          failed to meet any of the other limitations of this claim.                  
          Appellants have chosen not to argue any other specific                      
          limitations of the claims as a basis for patentability.  We                 
          are not required to raise and/or consider such issues.  As                  
          stated by our reviewing court in In re Baxter Travenol Labs.,               
          952 F.2d 388, 391, 21 USPQ2d 1281, 1285 (Fed. Cir. 1991),                   
          “[i]t is not the function of this court to examine the claims               
          in greater detail than argued by an appellant, looking for                  
          nonobvious distinctions over the prior art.”  37 CFR 1.192(a)               
          as amended at 58 CFR 545 Oct. 22, 1993, which was controlling               
          at the time of Appellants' filing the brief, states as                      
          follows:                                                                    




               The brief . . . must set forth the authorities and                     
               arguments on which the appellant will rely to                          
               maintain the appeal.  Any arguments or authorities                     
               not included in the brief may be refused                               
               consideration by the Board of Patent Appeals and                       
               Interferences, unless good cause is shown.                             
          Thus, 37 CFR §1.192 provides that just as the Court is not                  

                                          13                                          





Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007